Publications by authors named "Craig Flory"

Claim this Profile
P
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies.
Karim Azzag, Alessandro Magli, James Kiley, Darin Sumstad, Diane Kadidlo, Craig Flory

Mol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantable and Degradable Thermoplastic Elastomer.
Allison Siehr, Craig Flory, Trenton Callaway, Robert J Schumacher, Ronald A Siegel

ACS Biomater Sci Eng· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Preclinical Safety Study of Thyroid Hormone Instilled into the Lungs of Healthy Rats-an Investigational Therapy for ARDS.
Craig M Flory, Beverly J Norris, Nicole A Larson, Lia G Coicou, Brenda L Koniar

J Pharmacol Exp Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.
Sven-Ulrik Gorr, Craig M Flory, Robert J Schumacher

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity.
Lisa M Oppegard, Justine L Delgado, Chaitanya A Kulkarni, Tyrell R Towle, Delaney E Hart, Craig M Flory

Invest New Drugs· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Zhijun Guo, Irina F Sevrioukova, Ilia G Denisov, Xia Zhang, Ting-Lan Chiu, Craig M Flory

Cell Chem Biol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Zhijun Guo, Irina F Sevrioukova, Ilia G Denisov, Xia Zhang, Ting-Lan Chiu, Craig M Flory

Cell Chem Biol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis.
Astrid Jüngel, Caroline Ospelt, Mark Lesch, Melissa Thiel, Teresa Sunyer, Craig Flory

Ann Rheum Dis· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Melissa J Thiel, Caralee J Schaefer, Mark E Lesch, James L Mobley, David T Dudley, Craig M Flory

Arthritis Rheum· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
Christelle Boileau, Johanne Martel-Pelletier, Julie Brunet, Ginette Tardif, Denis Schrier, Craig Flory

Arthritis Rheum· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
Jean-Pierre Pelletier, Julio C Fernandes, Julie Brunet, Florina Moldovan, Denis Schrier, Craig Flory

Arthritis Rheum· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis